These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8089864)

  • 1. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.
    Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA
    J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.
    Nishizaki M; Fujiwara T; Tanida T; Hizuta A; Nishimori H; Tokino T; Nakamura Y; Bouvet M; Roth JA; Tanaka N
    Clin Cancer Res; 1999 May; 5(5):1015-23. PubMed ID: 10353734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct.
    Georges RN; Mukhopadhyay T; Zhang Y; Yen N; Roth JA
    Cancer Res; 1993 Apr; 53(8):1743-6. PubMed ID: 8467490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
    Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
    Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes.
    Zou Y; Zong G; Ling YH; Hao MM; Lozano G; Hong WK; Perez-Soler R
    J Natl Cancer Inst; 1998 Aug; 90(15):1130-7. PubMed ID: 9701362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.
    Fujiwara T; Grimm EA; Mukhopadhyay T; Cai DW; Owen-Schaub LB; Roth JA
    Cancer Res; 1993 Sep; 53(18):4129-33. PubMed ID: 8395976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
    Roth JA; Nguyen D; Lawrence DD; Kemp BL; Carrasco CH; Ferson DZ; Hong WK; Komaki R; Lee JJ; Nesbitt JC; Pisters KM; Putnam JB; Schea R; Shin DM; Walsh GL; Dolormente MM; Han CI; Martin FD; Yen N; Xu K; Stephens LC; McDonnell TJ; Mukhopadhyay T; Cai D
    Nat Med; 1996 Sep; 2(9):985-91. PubMed ID: 8782455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy of p53-wt and drug in an orthotopic multidrug-resistant human lung cancer model.
    Gao Z; Gao Z; Zhang T
    Sci China C Life Sci; 1997 Jun; 40(3):232-7. PubMed ID: 18726321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
    Zhang Y; Mukhopadhyay T; Donehower LA; Georges RN; Roth JA
    Hum Gene Ther; 1993 Aug; 4(4):451-60. PubMed ID: 8399492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wildtype (normal) p53.
    Roth JA
    Hum Gene Ther; 1996 May; 7(7):861-74. PubMed ID: 8860838
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene.
    Hwang RF; Gordon EM; Anderson WF; Parekh D
    Surgery; 1998 Aug; 124(2):143-50; discussion 150-1. PubMed ID: 9706132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-controlled p53 gene therapy for human non-small cell lung cancer xenografts in athymic nude mice via the CArG elements.
    Wang WD; Li R; Chen ZT; Li DZ; Duan YZ; Cao ZH
    Cancer Sci; 2005 Oct; 96(10):706-12. PubMed ID: 16232203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapy.
    Runnebaum IB; Kreienberg R
    Hybridoma; 1995 Apr; 14(2):153-7. PubMed ID: 7590773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.
    Cai DW; Mukhopadhyay T; Liu Y; Fujiwara T; Roth JA
    Hum Gene Ther; 1993 Oct; 4(5):617-24. PubMed ID: 8280799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
    Cai DW; Mukhopadhyay T; Roth JA
    Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer.
    Schuler M; Rochlitz C; Horowitz JA; Schlegel J; Perruchoud AP; Kommoss F; Bolliger CT; Kauczor HU; Dalquen P; Fritz MA; Swanson S; Herrmann R; Huber C
    Hum Gene Ther; 1998 Sep; 9(14):2075-82. PubMed ID: 9759934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer.
    Perdomo JA; Naomoto Y; Haisa M; Fujiwara T; Hamada M; Yasuoka Y; Tanaka N
    J Cancer Res Clin Oncol; 1998 Jan; 124(1):10-8. PubMed ID: 9498829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
    Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.